# FDA Inspection 1195425 - CSL Plasma, Inc. - January 05, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/dfbec216-fd8f-4d73-84f6-00d216cec834
Source feed: FDA_Inspections

> FDA Inspection 1195425 for CSL Plasma, Inc. on January 05, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1195425
- Company Name: CSL Plasma, Inc.
- Inspection Date: 2023-01-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1195425 - 2023-01-05](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/d622aed6-9e7f-477d-9117-0194af985704)
- [FDA Inspection 1025772 - 2017-09-08](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/53f10e0b-1dba-4467-a256-e032f52a78d9)
- [FDA Inspection 805215 - 2012-10-19](https://www.globalkeysolutions.net/records/fda_inspections/csl-plasma-inc/a7976eea-faf4-4c02-af08-e932e8eed58e)

Company: https://www.globalkeysolutions.net/companies/csl-plasma-inc/6812f94e-6862-4f3c-bb59-2927a488e095

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d